Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton London Docklands Riverside Hotel

Sep 19, 2018 8:00 AM - Sep 20, 2018 5:00 PM

265 Rotherhithe Street , London, SE16 5HW, United Kingdom

Global Clinical Trials Transparency Conference

Session 7: Public Accountability Around Disclosure and Where Are We Heading?

Session Chair(s)

Merete  Joergensen, MBA, MSc

Merete Joergensen, MBA, MSc

Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials

Merete-J Consulting CVR: 34920818, Denmark

New initiatives on how to improve, enforce and measure Data Sharing activities are being implemented and published. How are these measured? What has the impact been? How have organisations worked with these new initiatives? Future transparency ambitions, and how can we even get more out of these new initiatives?


Trish  Groves

Trish Groves

Deputy Editor

British Medical Journal, United Kingdom

Lise  Baltzer

Making Publications, Disclosure and Data Sharing Commitments Go Hand in Hand: Lise Baltzer

Director for Global Publications

Novo Nordisk, Denmark

Jennifer  Miller, PhD

Data sharing the new initiative under the Good Pharma Score Card: Jennifer Miller, PhD

Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics

Yale School of Medicine, United States

Ben  Goldacre

FDAAA TrialsTracker and the COMPare Trials project: Ben Goldacre

Senior Clinical Research Fellow, CEBM, Department of Primary Care Health Science

University of Oxford, United Kingdom

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.